Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use XPHOZAH® safely and effectively. See full prescribing information for XPHOZAH. XPHOZAH (tenapanor) tablets, for oral use Initial U.S. Approval: 2019
Medication labelWhy this: Advisory · dailymed-prescription
XPHOZAH is indicated to reduce serum phosphorus in adults with chronic kidney disease (CKD) on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.
- generic_name
- tenapanor
- product_names
- Tenapanor
- ndc
- 73154-110, 73154-120, 73154-130, 73154-110-14, 73154-110-60, 73154-110-99, 73154-120-14, 73154-120-60, 73154-120-99, 73154-130-14, 73154-130-60, 73154-130-99
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en